User:OtEP PR/Dr. Jonas Moses

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs
This page was last edited by Timrollpickering (talk | contribs) 5 years ago. (Update timer)

Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Submit your draft for review!

Dr. Jonas Moses new article content ...

Scientist, Innovator, Futurist, Author and Entrepreneur, Dr. Jonas Moses, is the Founder and CSO of notopos Corporation (dba notopos univers)^[1]. Dr. Moses is also the Founder and Executive Producer of On the Edge Productions LLC and Director/Host of the television series, “On the Edge.”^[2] He has been called “a visionary innovator, who’s assumed a leadership role” in the development of novel medical, scientific and technological devices, therapeutics, diagnostics, processes and procedures.^[3]

Dr. Moses began his professional career working in the Life Sciences, Environmental Engineering and clinical Medicine and has been involved in diverse medical-, scientific- and technology-related industries. He has consulted with scientists, physicians, governmental leaders, policy-makers, industry professionals and academes, throughout the United States, Eastern and Western Europe, Africa, Asia, South America and Australia. Dr. Moses has spoken on a broad spectrum of Innovation, Technology and Public Policy subjects, before diverse professional audiences across the United States. He has also been interviewed on several syndicated radio talk shows – including his recent appearance on “The Gary Null Show” (broadcast over National Public Radio)^[4] and the syndicated “Robert Scott Bell Show”^[5] – on themes such as “Public Health Policy and Infectious Diseases.”

By training and education, Dr. Moses is a Biomedical Engineer (Ph.D. in Cell and Tissue Engineering), having previously trained in surgery and disease of the eye - (Ophthalmology) during a several-year stint in the United States Army. He received his PhD from the University of Illinois-Chicago, predicated upon his work as a cancer researcher and his subsequent dissertation entitled “Platelets, Cytoplasts and Extra Cellular Matrix in the Bio-Engineering of a 3-Dimensional, In Vitro Tumor Model.”^[6] While working on his doctorate, he was also a prolific research scientist, engaged in the cell and developmental biology of cancer. During his tenure at the University of Illinois, Dr. Moses, along with colleagues, concepted and/or developed several patent-worthy innovations.^[7]

Although the majority of his background is based in the Sciences, Medicine and Technology, Dr. Moses possesses a substantial fund of corporate knowledge and experience, as he spent several years developing his real-world business skills in the disciplines of strategic planning, organizational development, change management and corporate visioning - having been a consultant to and/or the Founder or Co-Founder of multiple successful ventures.

References[edit]

^ see Dun&Bradstreet Corporate Reports: notopos Corporation, a Delaware Corporation, notopos Corporation website, http://www.notopos.com
^ On the Edge Productions, http://www.ontheedgestudios.com; InTimeTV, http://intimetv.com/medical/ote.cfm; notopos Channel, http://www.YouTube.com/users/notopos
^ Excerpted from a quote by Celia Farber - author, producer and journalist for SPIN, Rolling Stone, Esquire, Harper's, Newsmax, Salon.com, Gear, the New York Press, Red Flags, and others, in reference to a 2008 review of Dr. Moses' television series, "On the Edge,".
^ The Gary Null Show – 05/08/09
^ The Robert Scott Bell Show, Mon, 20 Apr 2009
^ University of Illinois Press (2007)
^ 1) “ECM Matrix Bio-assay Chip – a Novel Method of Cancer Detection” (2003, patent-pending); 2) “Compositions and Methods for Multi-dimensional Printing of Cells and Tissues” (2004, patent pending, with Daniel Murauski); 3) “Methods and Compositions for Piercing Studs with Bioactive Polymer Coating” (2004, provisional patent, with Daniel Murauski); 2007, utility patent-pending); 4) “A Novel, Auto-focusing, Intraocular Lens Implant System” (2006, patent-pending) 5) “A Portable, Self-contained and Semi-disposable Bioreactor” (2006, revised patent-pendiong); 6) “IV Secure Split and Separator” (2007, provisional patent, with Daniel Murauski); 7) “Intra-tumoral Micro-Imaging Utilizing Dye-labeled Nanospheres with an Autologous-derived, Bioactive Coating” (2007, patent-pending, with Daniel Murauski) 8) “Intra-tumoral Delivery of Nanospheres imbued with an Autologous-derived, Bioactive Coating, in the Treatment of Neoplasias” (2007, patent-pending, with Daniel Murauski)

External links[edit]

example.com

[1] On the Edge television series [2] [3] http://www.intimetv.com ]

[1] see Dun&Bradstreet Corporate Reports: notopos Corporation, a Delaware Corporation, notopos Corporation website, http://www.notopos.com

[2] On the Edge Productions, http://www.ontheedgestudios.com; InTimeTV, http://intimetv.com/medical/ote.cfm; notopos Channel, http://www.YouTube.com/users/notopos

[3] Excerpted from a quote by Celia Farber - author, producer and journalist for SPIN, Rolling Stone, Esquire, Harper's, Newsmax, Salon.com, Gear, the New York Press, Red Flags, and others, in reference to a 2008 review of Dr. Moses' television series, "On the Edge,".

[4] The Gary Null Show – 05/08/09

[5] The Robert Scott Bell Show, Mon, 20 Apr 2009

[6] University of Illinois Press (2007)

[7] 1) “ECM Matrix Bio-assay Chip – a Novel Method of Cancer Detection” (2003, patent-pending); 2) “Compositions and Methods for Multi-dimensional Printing of Cells and Tissues” (2004, patent pending, with Daniel Murauski); 3) “Methods and Compositions for Piercing Studs with Bioactive Polymer Coating” (2004, provisional patent, with Daniel Murauski); 2007, utility patent-pending); 4) “A Novel, Auto-focusing, Intraocular Lens Implant System” (2006, patent-pending) 5) “A Portable, Self-contained and Semi-disposable Bioreactor” (2006, revised patent-pendiong); 6) “IV Secure Split and Separator” (2007, provisional patent, with Daniel Murauski); 7) “Intra-tumoral Micro-Imaging Utilizing Dye-labeled Nanospheres with an Autologous-derived, Bioactive Coating” (2007, patent-pending, with Daniel Murauski) 8) “Intra-tumoral Delivery of Nanospheres imbued with an Autologous-derived, Bioactive Coating, in the Treatment of Neoplasias” (2007, patent-pending, with Daniel Murauski)

[1]

[2]

[3]

[4]

[5]

[6]

[7]